COMP <GO>
SEPN vs SLS // REVENUE GROWTH (YOY)
Septerna Inc. (NASDAQ) VS. SELLAS Life Sciences Group Inc. (NASDAQ) • 15-METRIC TALLY: SEPN 5
— SLS 0
■ METRIC PARITY
LAST: $45.23 (+2.22%) • MKT CAP: $2.11B
revenue-growth
180.00%
LAST: $10.15 (-2.17%) • MKT CAP: $2.05B
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SEPN VS. SLS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SEPN | SLS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -20.70% | -21.80% | +1.10 | SEPN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.19% | -1.38% | +6.57 | SEPN | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.87 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 2/9 | +4.00 | SEPN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.2 | 42.3 | +25.90 | SEPN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.11B | $2.05B | $60.4M | SEPN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SEPN REV | SLS REV | SEPN GROSS % | SLS GROSS % | SEPN FCF | SLS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $46.0M | $0 | — | — | $109.7M | -$28.4M |
| FY 2024 | $1.1M | $0 | — | — | -$69.6M | -$35.4M |
| FY 2023 | $151.0K | $0 | — | — | -$38.7M | -$31.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SEPN // BETA —
SLS // BETA —